Opérations
Qui sommes-nous ?
L’entreprise
Equipe
Nos bureaux
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Conseil en matière de dette
Equity Research
Levées de Fonds – Séries A, B, C ….
Stratégie et préparation de l’introduction en bourse
Industries
Services aux Entreprises
Consumer / Retail / E-commerce
Technologie industrielle
Life science et Santé
Software / TMT
Career
Evénements
Insights
News
Company News
Deal News
Carlsquare in the Media
Newsletter
Contactez-nous
Newsletter
FR
INT
DA
DE
SV
US
Main menu button
Equipe
Opérations
Contact
Equipe
Opérations
Contact
Actualités
Tout
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Enrad
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
GIAB
H&D Wireless
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Medclair Invest
Midsummer
Mindark PE
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
Ytrade Group
Zazz Energy
Zinzino
Tout
Company News
Deal News
Equity Research
Events
Insights
Macro and markets
Media
04 Avr 2023
Carlsquare has merged with Silicon Valley-based tech investment bank Capital Clarity
Company News
18 Juil 2025
Equity Research KlaraBo, Q2 2025: Focus on renovation and acquisitions
Equity Research
KlaraBo
17 Juil 2025
Carlsquare advised the exiting founding shareholder in the reorganisation of the Bihl+Wiedemann shareholder structure
Deal News
17 Juil 2025
Equity Research KlaraBo, Q2 2025: Good momentum in the renovation of apartments
Equity Research
KlaraBo
17 Juil 2025
Equity Research ALM Equity, Q2 2025: The turnaround delayed until the end of 2025
Equity Research
ALM Equity
16 Juil 2025
Equity research CDON Q2 2025: Back to growth sooner than expected
Equity Research
CDON
16 Juil 2025
Carlsquare advised the shareholders of Svenskt Kosttillskott on the sale to Vision Healthcare
Deal News
15 Juil 2025
Equity research CDON Q2 2025: Back to growth
Equity Research
CDON
14 Juil 2025
Equity research Zinzino Q2 2025: Ahead of the curve
Equity Research
Zinzino
11 Juil 2025
Equity Research Nosa Plugs: Positive results and proof of concept
Equity Research
Nosa Plugs
10 Juil 2025
Carlsquare advised Scanbot SDK on its sale to Apryse
Deal News
08 Juil 2025
Carlsquare advised Waterland and netgo on the sale of MEHRWERK to Fortino Capital
Deal News
07 Juil 2025
Carlsquare advised HanseYachts AG and AURELIUS on the successful ownership transition to Müller Verwaltung and CEO Hanjo Runde
Deal News
02 Juil 2025
Equity research Immunovia: PancreaSure test achieves CPT code assignment
Equity Research
Immunovia
02 Juil 2025
Equity Research ALM Equity, Q2 2025: More housing starts are expected in the second half of the year
Equity Research
ALM Equity
01 Juil 2025
Carlsquare SaaSalon Berlin 2025
Events
01 Juil 2025
Carlsquare advised Lafayette on the sale of Münsterland to Nomadic, a brand of Kerga and portfolio company of BiaVest
Deal News
01 Juil 2025
Equity Research KlaraBo, Q2 2025: Should benefit from lower interest rates
Equity Research
KlaraBo
30 Juin 2025
Equity research CDON, Q2 2025: We expect a small step forward
Equity Research
CDON
24 Juin 2025
Carlsquare advised Odinwell AB on a rights issue of units
Deal News
18 Juin 2025
Carlsquare advised Tales & Tails on the sale of a majority stake to petsnova Group
Deal News
1
2
3
…
91